Trial Profile
A long-term extension study of AG-1749 in patients on concomitant long-term non-steroidal antiinflammatory drug (NSAIDs) use
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 03 Jun 2016
Price :
$35
*
At a glance
- Drugs Lansoprazole (Primary)
- Indications Gastrointestinal ulcer
- Focus Adverse reactions
- Sponsors Takeda
- 03 Jun 2016 New trial record